Cargando…
Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population
BACKGROUND: CYP2C9*3 allele has been reported to correlate with increased plasma concentration of fluvastatin active form in healthy volunteers. We analyzed the correlation between the CYP2C9 genotype and cholesterol-lowering effect of fluvastatin in human hypercholesterolemic patients. MATERIAL/MET...
Autores principales: | Buzková, Helena, Pechandová, Kristina, Danzig, Vilém, Vařeka, Tomáš, Perlík, František, Žák, Aleš, Slanař, Ondřej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560696/ https://www.ncbi.nlm.nih.gov/pubmed/22847201 http://dx.doi.org/10.12659/MSM.883272 |
Ejemplares similares
-
Psychoactive Medication, Violence, and Variant Alleles for Cytochrome P450 Genes
por: Eikelenboom-Schieveld, Selma J. M., et al.
Publicado: (2021) -
Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?
por: Zeman, Miroslav, et al.
Publicado: (2015) -
Enantiospecific Pharmacogenomics of Fluvastatin
por: Hirvensalo, Päivi, et al.
Publicado: (2019) -
Congenital cataract, facial dysmorphism and demyelinating neuropathy (CCFDN) in 10 Czech gypsy children – frequent and underestimated cause of disability among Czech gypsies
por: Lassuthova, Petra, et al.
Publicado: (2014) -
Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study
por: Naujokaitis, Domas, et al.
Publicado: (2021)